Search for: "Illumina v. FTC"
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
16 Jan 2024, 11:28 am
The post FTC v. [read post]
21 Dec 2023, 12:29 pm
Alas, that is not the case with the Fifth Circuit’s decision in Illumina v. [read post]
9 Dec 2022, 8:28 am
England v. [read post]
14 Jul 2023, 1:22 pm
The FTC in Illumina, however, provides no authority for this proposition, nor could it. [read post]
13 Oct 2023, 12:44 pm
In Illumina v. [read post]
21 Oct 2021, 6:50 am
Specifically, the FTC avers that Illumina’s acquisition of Grail will “lessen competition in the U.S. [read post]
14 Sep 2023, 6:00 am
Part 1 of this piece can be found here. [read post]
24 Jun 2023, 12:20 pm
The FTC v. [read post]
25 Jan 2024, 6:32 am
It also succeeded in blocking the Illumina/Grail merger by partly winning in the 5th U.S. [read post]
27 Apr 2023, 4:25 am
FTC. https://www.competitionpolicyinternational.com/illumina-granted-fast-track-appeal-of-ftc-order/? [read post]
8 Apr 2023, 2:35 am
’s motion to expedite in its litigation with the FTC surrounding Illumina’s acquisition of Grail, Inc.* Unsurprisingly, this case was filed in the Fifth Circuit. [read post]
8 Apr 2023, 2:35 am
’s motion to expedite in its litigation with the FTC surrounding Illumina’s acquisition of Grail, Inc.* Unsurprisingly, this case was filed in the Fifth Circuit. [read post]
29 Jun 2023, 7:18 am
Failing to receive a prompt response, Geldon added “[v]ery telling that you don’t even respond to text messages now that you don’t need help getting confirmed. [read post]
24 Jul 2023, 3:59 pm
(We covered this topic in a recent Fifth Circuit amicus brief supporting Illumina.) [read post]
15 Apr 2021, 10:51 am
Illumina, Inc., et al., No. 20-892. [read post]
1 May 2023, 3:30 am
We're not at the point where an Illumina-Grail approach--closing the deal without regulatory approval--would merely be contemplated. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
